and pharmacokinetics of atumelnant when administered for 12 weeks in people with CAH caused by 21-hydroxylase deficiency. The study enrolled 28 patients across 3 dose cohorts with classic CAH on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback